Last 32 quarters of trend data · Healthcare · Healthcare Software & Telehealth
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.55 | 0.82 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.40 | 0.58 | 0.52 | 0.33 | 0.57 | 0.66 | 0.81 | 0.98 | 1.38 | 1.61 | 1.25 | 1.48 | 1.77 | 1.94 | 2.39 | 2.19 | 2.09 | 1.93 | 2.75 | 5.11 | 7.98 |
| — | -11.2% | -35.8% | -66.7% | -59.0% | -59.2% | -34.9% | -33.8% | -21.8% | -17.2% | -47.8% | -32.6% | -15.4% | +1.0% | -13.2% | -57.1% | -73.7% | -80.6% | -73.6% | -44.4% | -8.3% | |
| P/B Ratio | 0.42 | 0.90 | 1.46 | 0.67 | 0.69 | 0.60 | 0.76 | 0.82 | 1.21 | 1.39 | 1.06 | 1.24 | 1.45 | 1.50 | 1.79 | 1.60 | 1.36 | 1.20 | 1.66 | 2.89 | 3.95 |
| — | +49.3% | +93.3% | -19.0% | -42.8% | -56.4% | -28.8% | -33.3% | -16.8% | -7.7% | -40.9% | -22.7% | +6.4% | +25.4% | +8.2% | -44.7% | -65.5% | -73.2% | -81.6% | -62.1% | -41.1% | |
| P/FCF | 4.20 | 4.45 | — | 1.70 | 4.40 | — | — | — | — | 68.60 | — | 14.82 | — | 23912.97 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | -99.7% | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 4.09 | 0.39 | — | 9.45 | 4.49 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.5% | 42.7% | 49.5% | 33.4% | 52.7% | 49.5% | 47.4% | 45.6% | 43.6% | 44.6% | 47.2% | 48.5% | 40.6% | 43.4% | 46.1% | 48.1% | 44.9% | 46.8% | 51.0% | 50.1% | 47.7% |
| — | -13.8% | +4.4% | -26.7% | +21.0% | +11.1% | +0.3% | -5.8% | +7.3% | +2.8% | +2.4% | +0.6% | -9.5% | -7.4% | -9.6% | -3.8% | -5.8% | +0.9% | +2.8% | -1.9% | -5.1% | |
| Operating Margin | -11.6% | 89.1% | -51.8% | -9.5% | 4.4% | -22.9% | -46.0% | -25.4% | -22.0% | -17.9% | -20.8% | -30.5% | -43.7% | -33.3% | -47.3% | -47.3% | -53.1% | -66.9% | -47.0% | -35.8% | -69.2% |
| — | +488.3% | -12.6% | +62.5% | +119.9% | -28.0% | -120.7% | +16.8% | +49.7% | +46.2% | +56.0% | +35.4% | +17.8% | +50.2% | -0.6% | -32.2% | +23.2% | +2.3% | +13.3% | +17.9% | +5.3% | |
| Net Margin | -57.2% | 72.0% | -57.5% | -156.9% | -121.9% | -29.1% | -50.8% | -29.9% | -26.0% | -19.3% | -17.8% | -27.6% | -40.4% | -29.9% | -44.5% | -44.9% | -51.7% | -66.9% | -47.3% | -33.0% | -75.7% |
| — | +347.0% | -13.3% | -424.9% | -369.4% | -51.0% | -185.1% | -8.5% | +35.7% | +35.4% | +60.0% | +38.7% | +22.0% | +55.4% | +5.9% | -36.2% | +31.7% | -3.2% | +21.3% | +35.1% | +6.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -58.3% | 32.9% | -33.9% | -57.8% | -31.5% | -6.5% | -11.3% | -6.4% | -5.7% | -4.1% | -3.8% | -5.7% | -8.1% | -5.7% | -8.2% | -8.0% | -8.3% | -10.1% | -7.0% | -4.5% | -9.1% |
| — | +602.3% | -199.9% | -803.8% | -448.9% | -58.2% | -198.9% | -12.5% | +29.0% | +27.5% | +53.9% | +28.9% | +2.2% | +43.3% | -16.6% | -78.6% | +9.5% | -3.7% | +46.5% | +57.0% | +38.8% | |
| ROA | -26.1% | 13.6% | -10.5% | -24.3% | -16.7% | -3.7% | -5.4% | -2.7% | -2.5% | -2.0% | -1.9% | -2.9% | -4.3% | -3.1% | -4.4% | -4.4% | -4.7% | -5.8% | -4.1% | -2.7% | -5.8% |
| — | +467.8% | -93.5% | -794.8% | -575.5% | -88.8% | -178.9% | +8.0% | +42.3% | +36.2% | +55.9% | +33.2% | +8.5% | +46.7% | -8.2% | -62.8% | +19.8% | -1.4% | +35.3% | +45.1% | +22.0% | |
| ROIC | -6.1% | 23.7% | -11.9% | -1.6% | 0.6% | -2.8% | -6.1% | -3.2% | -2.9% | -2.6% | -2.9% | -3.7% | -4.7% | -3.5% | -5.0% | -4.9% | -4.9% | -6.2% | -4.6% | -3.4% | -6.7% |
| — | +941.0% | -94.3% | +48.1% | +120.4% | -8.9% | -109.2% | +15.3% | +38.5% | +25.7% | +41.1% | +23.1% | +4.5% | +44.0% | -7.1% | -41.9% | +26.1% | +26.9% | +42.1% | +32.9% | +13.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.70 | 0.11 | 1.69 | 1.23 | 0.70 | 0.52 | 0.50 | 1.07 | 1.10 | 1.03 | 0.70 | 0.70 | 0.68 | 0.65 | 0.64 | 0.61 | 0.58 | 0.56 | 0.53 | 0.52 | 0.39 |
| — | -79.1% | +239.1% | +15.6% | -36.7% | -49.5% | -28.6% | +53.3% | +62.3% | +57.4% | +8.8% | +13.9% | +16.3% | +15.6% | +20.9% | +18.3% | +48.9% | +53.3% | -26.8% | -29.6% | -44.6% | |
| Debt / EBITDA | 11.89 | 0.26 | — | 31.78 | 10.61 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.89 | 1.70 | 2.70 | 1.69 | 1.89 | 1.88 | 1.83 | 1.24 | 1.43 | 1.41 | 1.18 | 4.31 | 4.42 | 4.85 | 4.74 | 4.24 | 5.18 | 4.87 | 5.15 | 5.21 | 5.46 |
| — | -9.6% | +47.9% | +36.1% | +32.3% | +33.2% | +54.5% | -71.1% | -67.7% | -70.9% | -75.0% | +1.6% | -14.8% | -0.4% | -8.1% | -18.6% | -5.1% | +148.9% | +308.6% | +316.0% | +45.8% | |
| Quick Ratio | 1.89 | 1.70 | 2.70 | 1.69 | 1.89 | 1.88 | 1.83 | 1.24 | 1.43 | 1.41 | 1.18 | 4.31 | 4.42 | 4.85 | 4.74 | 4.24 | 5.18 | 4.87 | 5.15 | 5.21 | 5.46 |
| — | -9.6% | +47.9% | +36.1% | +32.3% | +33.2% | +54.5% | -71.1% | -67.7% | -70.9% | -75.0% | +1.6% | -14.8% | -0.4% | -8.1% | -18.6% | -5.1% | +148.9% | +308.6% | +316.0% | +45.8% | |
| Interest Coverage | -9.81 | 92.85 | -8.66 | -22.33 | -15.43 | -2.94 | -6.07 | -2.22 | -1.75 | -2.73 | -6.33 | -10.19 | -15.52 | -11.05 | -16.86 | -17.23 | -18.69 | -24.17 | -18.00 | -13.41 | -9.80 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 32 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HCAT stock.
Health Catalyst, Inc.'s current P/E is -0.5x. The average P/E over the last 1 quarters is 0.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Health Catalyst, Inc.'s current operating margin is -11.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Health Catalyst, Inc.'s business trajectory between earnings reports.